Wednesday, April 22, 2020 8:23:04 AM
Not heartbeat, more like heart attack when FDA shoots this submission down
Again, the Phase 2b submission doesn't stand a chance.
A Phase 1 submission has better than even odds of approval. Assuming certain changes were made.
So why didn't Kenny go with a Phase 1? Because his pump is a Phase 2b will be approved, after 6 months victory, and it goes flying through Phase 3 into the market in a year. Whereas with Phase 1, it's 6 months-1 yr, followed by 2-4 yrs for Phase 2, and another 2-4 yrs for Phase 3.
But that's not the problem. Even before Covid "pay as you go" for funding a CT was nonsense. Now even more nonsensical.
Then there's the problem of obtaining full enrollment for a PC clinical trial. CTs in late stage testing, with very good prior earlier trial data are taking 6-12 months to obtain full enrollment. Along comes Kenny... convincing SHs, patients are going to flock into a CT featuring the Kenny Wonder Treatment with no prior clinical data to back it up. There will be no quicky CT. Not happening. Likely would take years to obtain full enrollment.
Who knows what the PPS might do as a result of irrational retail reaction. But GL in trying to keep 1.5B shares up. The 3rd parties aren't paying $15K/month for PR pumps, so that retail can gain profit. They are paying the $15K/month so that they can dump into any irrational retail buying.
Again, the Phase 2b submission doesn't stand a chance.
A Phase 1 submission has better than even odds of approval. Assuming certain changes were made.
So why didn't Kenny go with a Phase 1? Because his pump is a Phase 2b will be approved, after 6 months victory, and it goes flying through Phase 3 into the market in a year. Whereas with Phase 1, it's 6 months-1 yr, followed by 2-4 yrs for Phase 2, and another 2-4 yrs for Phase 3.
But that's not the problem. Even before Covid "pay as you go" for funding a CT was nonsense. Now even more nonsensical.
Then there's the problem of obtaining full enrollment for a PC clinical trial. CTs in late stage testing, with very good prior earlier trial data are taking 6-12 months to obtain full enrollment. Along comes Kenny... convincing SHs, patients are going to flock into a CT featuring the Kenny Wonder Treatment with no prior clinical data to back it up. There will be no quicky CT. Not happening. Likely would take years to obtain full enrollment.
Who knows what the PPS might do as a result of irrational retail reaction. But GL in trying to keep 1.5B shares up. The 3rd parties aren't paying $15K/month for PR pumps, so that retail can gain profit. They are paying the $15K/month so that they can dump into any irrational retail buying.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
